090729-Xention-web-top-#3D2

Publications - Papers


Carbon-14 radiosynthesis of 4-(5-chloro- 2-hydroxyphenyl)-3-(2-hydroxyethyl)-6- (trifluoromethyl)-[4-14C]quinolin-2(1H)-one (XEN-D0401), A novel BK channel activator

Sean L. Kitson, Stuart Jones, William Watters, Fiona Chan and David Madge, (2010): Labelled Compounds and Radiopharmaceuticals

Near-Thorough QT Study as Part of a First-In-Man Study

Malik, M., Hnatkova, K., Ford, J. and Madge, D. (2008): Journal of Clinical Pharmacology; 48, 1146-1157

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

Ford, JW. and Milnes, JT., (2008): J Cardiovasc Pharmacol; 52, 105-120

Prediction of Ion Channel Activity using Binary Kernel Discrimination

Willett, P., Wilton, D., Hartzoulakis, B., Tang, R., Ford, J. and Madge, D., (2007): J. Chem. Inf. Model; 47, 1961-1966.

Publications - Posters


Biophysical Society, Boston, 2009

Biophysical characterization of duloxetine activity on voltage-gated sodium channels involved in pain transmission

British Pharmacological Society, Brighton, 2008

Development of a hKv1.3 ion channel screening assay using the QPatch 16 automated patch-clamp platform

American Heart Association, New Orleans, 2008

The Atrial Antiarrhythmic Drug XEN-D0101 Selectively Inhibits the Human Ultra-Rapid Delayed-Rectifier Potassium Current (IKur) Over Other Cardiac Ion Channels

British Pharmacological Society, Bournemouth, 2007

Targeting the hKv1.3 potassium channel in the development of novel treatments for autoimmune diseases

2nd International Congress on Neuropathic Pain, Berlin, 2007

State-Dependent Inhibitors of the Nav1.3 Sodium Channel for Treating Neuropathic Pain

British Pharmacological Society, London, 2005

Targeting the Nav1.3 Sodium Channel in the Development of Novel Treatments for Neuropathic Pain

Society for Neuroscience, New Orleans, 2003

A comparison of the effects of known Ion Channel Modulators against A K+ current recorded using autopatch & ‘conventional’ Ion Channel Screening technologies